Table 2 List of 40 genes that have CNAs significantly different between clusters A and B
Probe name | Location | Name of Gene | Description | P-value | Pvalue after Bonferroni correction |
|---|---|---|---|---|---|
A_16_P41637097 | Xp21.2 | DMD | dystrophin | 4.541E-08 | 1.251E-04 |
A_14_P133591 | 5q21-q22 | APC | adenomatous polyposis coli | 5.774E-08 | 1.591E-04 |
A_14_P130973 | 4q11-q12 | *KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 1.047E-07 | 2.886E-04 |
A_14_P125447 | 13q12-q14 | SMAD9 | SMAD family member 9 | 1.373E-07 | 3.784E-04 |
A_14_P100439 | 12q24.3 | *RAN | member RAS oncogene family | 1.876E-07 | 5.171E-04 |
A_14_P102616 | 20q11.2 | GDF5 | growth differentiation factor 5 | 2.828E-07 | 7.794E-04 |
A_14_P133647 | 11q23.3 | **ETS1 | v-etserythroblastosis virus E26 oncogene homolog 1 (avian) | 5.603E-07 | 0.0015 |
A_14_P138640 | 5p14.3 | CDH18 | cadherin 18, type 2 | 6.138E-07 | 0.0017 |
A_14_P128664 | 18q23 | ATP9B | ATPase, class II, type 9B | 6.474E-07 | 0.0018 |
A_14_P124801 | 19p12 | PBX4 | pre-B-cell leukemia homeobox 4 | 1.010E-06 | 0.0028 |
A_14_P118423 | Xq28 | *RAB39B | member RAS oncogene family | 1.573E-06 | 0.0043 |
A_14_P134602 | 17q11.2 | NF1 | neurofibromin 1 | 1.802E-06 | 0.0050 |
A_14_P120351 | 5q31.1 | IL5 | interleukin 5 (colony-stimulating factor, eosinophil) | 1.988E-06 | 0.0055 |
A_14_P125637 | 6q16.1 | **EPHA7 | EPH receptor A7 | 2.153E-06 | 0.0059 |
A_14_P100300 | 13q12-q14 | SMAD9 | SMAD family member 9 | 2.525E-06 | 0.0070 |
A_14_P201681 | 7p21.1 | ITGB8 | integrin, beta 8 | 2.589E-06 | 0.0071 |
A_14_P130112 | Xp22.2 | *RAB9A | RAB9A, member RAS oncogene family | 2.949E-06 | 0.0081 |
A_14_P120484 | 1q41 | RPS6KC1 | ribosomal protein S6 kinase, 52 kDa, polypeptide 1 | 3.052E-06 | 0.0084 |
A_16_P16709446 | 4q13.1 | **EPHA5 | EPH receptor A5 | 3.584E-06 | 0.0099 |
A_14_P201127 | 2q32 | DLX2 | distal-less homeobox 2 | 3.703E-06 | 0.0102 |
A_14_P126957 | 11p11.2 | **SPI1 | spleen focus forming virus (SFFV) proviral integration oncogene | 4.334E-06 | 0.0119 |
A_14_P104667 | 8q22.2 | STK3 | serine/threonine kinase 3 | 4.386E-06 | 0.0121 |
A_14_P137889 | 14q13.3 | NKX2-8 | NK2 homeobox 8 | 5.393E-06 | 0.0149 |
A_14_P109970 | 1p36.1-p35 | **EPHB2 | Eph receptor B2 | 6.637E-06 | 0.0183 |
A_14_P118116 | Xp21.2 | DMD | dystrophin | 8.087E-06 | 0.0223 |
A_16_P01378894 | 5q34 | ATP10B | ATPase, class V, type 10B | 8.165E-06 | 0.0225 |
A_14_P139456 | 17q25.1 | *RAB37 | member RAS oncogene family | 1.001E-05 | 0.0276 |
A_14_P111361 | 17q21.2 | KRT33B | keratin 33B | 1.069E-05 | 0.0295 |
A_14_P134909 | 19p13.3-p13.2 | INSR | insulin receptor | 1.110E-05 | 0.0306 |
A_16_P02740008 | 13q12 | ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 | 1.129E-05 | 0.0311 |
A_14_P102858 | 1q42 | KIAA1804 | mixed lineage kinase 4 | 1.155E-05 | 0.0318 |
A_14_P113857 | 12p13 | **ETV6 | ets variant 6 | 1.172E-05 | 0.0323 |
A_14_P115054 | 16q22.3 | ZFHX3 | zinc finger homeobox 3 | 1.180E-05 | 0.0325 |
A_14_P138431 | 1p32-p31 | ROR1 | receptor tyrosine kinase-like orphan receptor 1 | 1.209 E-05 | 0.0333 |
A_18_P22746653 | 3p25.3 | ATP2B2 | ATPase, Ca++ transporting, plasma membrane 2 | 1.282E-05 | 0.0353 |
A_14_P105811 | 11q13 | MEN1 | multiple endocrine neoplasia I | 1.318E-05 | 0.0363 |
A_14_P136621 | 18q11.2 | CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 1.420E-05 | 0.0391 |
A_14_P103176 | 1p34.3 | **EPHA10 | EPH receptor A10 | 1.455E-05 | 0.0401 |
A_16_P17370843 | 5q34 | ATP10B | ATPase, class V, type 10B | 1.556E-05 | 0.0429 |
A_14_P108129 | 5p15.33 | *TERT | telomerase reverse transcriptase | 1.584E-05 | 0.0436 |
A_16_P19750359 | 13q12 | ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 | 1.586E-05 | 0.0437 |
A_14_P200005 | 1p36 | ATP13A2 | ATPase type 13A2 | 1.586E-05 | 0.0437 |
A_16_P01183532 | 5p15.2 | **TRIO | trio Rho guanine nucleotide exchange factor | 1.786E-05 | 0.0492 |